Advertisement
Advertisement

DMAC

DMAC logo

DiaMedica Therapeutics Inc. Common Stock

6.26
USD
Sponsored
-0.06
-0.95%
May 13, 15:59 UTC -4
Closed
exchange

Pre-Market

6.26

0.00
0.00%

DiaMedica Therapeutics Inc. Common Stock Profile

About

DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota.

Info & Links

CEO

Rick Pauls

Headquarters

301 CARLSON PARKWAY, SUITE 210
MINNEAPOLIS, MN 55305, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.diamedica.com

Auditor

Baker Tilly US, LLP

Share holders

43

Employees

35

DiaMedica Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

337.31M

Enterprise Value

321.68M

Enterprise Value/EBITDA(ttm)

-9.11

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.74

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-77.72%

Return on Invested Capital(ttm)

-83.29%

Return on Assets(ttm)

-69.54%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-35.30M

Net Income Available to Common(ttm)

-32.77M

Diluted EPS(ttm)

-0.70

Share Statistics

Beta (5Y Monthly)

1.16

52-Week Change

57.29%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

53.88M

Dividend Yield

0.00%

Float4

49.95M

% Held by Insiders

7.30%

% Held by Institutions

10.12%

Balance Sheet

Total Cash(mrq)

59.89M

Total Cash Per Share(mrq)

1.11

Total Debt(mrq)

15.00K

Total Debt/Equity(mrq)

0.03%

Current Ratio(mrq)

11.81%

Quick Ratio(mrq)

11.81%

Book Value Per Share(mrq)

1.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.62

Free Cash Flow(ytd)

-29.10M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement